PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
J Thromb Haemost. Author manuscript; available in PMC 2010 July 1.
Published in final edited form as:
PMCID: PMC2839880
NIHMSID: NIHMS183481

Protein-membrane interactions: Blood clotting on nanoscale bilayers

Summary

The clotting cascade requires the assembly of protease-cofactor complexes on membranes with exposed anionic phospholipids. Despite their importance, protein-membrane interactions in clotting remain relatively poorly understood. Calcium ions are known to induce anionic phospholipids to cluster, and we propose that clotting proteins assemble preferentially on such anionic lipid-rich microdomains. Until recently, there was no way to control the partitioning of clotting proteins into or out of specific membrane microdomains, so experimenters only knew the average contributions of phospholipids to blood clotting. The development of nanoscale membrane bilayers (Nanodiscs) has now allowed us to probe, with nanometer resolution, how local variations in phospholipid composition regulate the activity of key protease-cofactor complexes in blood clotting. Furthermore, exciting new progress in solid-state NMR and large-scale molecular dynamics simulations are allowing structural insights into interactions between proteins and membrane surfaces with atomic resolution.

Keywords: membranes, phospholipids, microdomains, GLA-domains, cofactors

Introduction

Most steps of the clotting cascade require a collection of serine proteases, protein cofactors, and protein substrates to assemble on a membrane surface. A suitable surface typically contains a mixture of neutral and anionic phospholipids, such as might be encountered following platelet activation or cell damage. While many anionic lipids can stimulate clotting reactions, phosphatidylserine (PS) is by far the most active. Membrane binding of blood clotting proteins is essential, since releasing these proteins from the membrane surface reduces their catalytic activities many thousand-fold [1]. How anionic membrane surfaces accelerate clotting reactions is not known with certainty, but a variety of explanations have been offered, including by increasing the local concentration of reactants, inducing specific conformational changes, and restricting the movement of proteins to two dimensions. In spite of the critical importance of membrane binding to blood clotting, we lack a detailed understanding of how any blood clotting protein interacts with phospholipid surfaces. This review focuses on recent advances that are permitting new insights into the role of the phospholipid bilayer in blood clotting.

Membrane microdomains and nanodomains

Plasma membranes contain membrane microdomains in which the local lipid and protein composition can vary from the bulk membrane. Notable examples include cholesterol- and sphingolipid-rich lipid rafts and caveolae [2,3]. Blood clotting reactions are typically studied on liposomes composed of mixtures of PS and neutral phospholipids like phosphatidylcholine (PC), but even such liposomes can spontaneously form membrane subdomains. For example, studies of giant unilamellar vesicles made from mixtures of anionic and neutral phospholipids demonstrated that Ca2+ could induce the anionic phospholipids to move over relatively long distances, coalescing into microdomains that were visible by light microscopy. Clustering became more pronounced in the presence of both Ca2+ and membrane-binding proteins [4,5]. These findings suggest that clotting proteins are likely to partition into or out of specific microdomains, seeking the membrane composition for which they have the highest affinity. We propose that blood clotting reactions take place preferentially on membrane “hot spots” consisting of Ca2+-induced clusters of anionic phospholipids. Moreover, we further suggest that there are local differences in anionic lipid content at the nanometer scale. Unfortunately, we typically know only the average composition of the lipid bilayers that are used in experiments. A complete explanation of how membrane surfaces contribute to blood clotting requires an understanding of the composition of membrane nanodomains together with a picture, at atomic resolution, of how the membrane binding domains of blood clotting engage the bilayer.

Stabilized nanoscale bilayers (Nanodiscs) as a unique platform for studying protein-membrane interactions

Stabilized, nanometer-scale phospholipid bilayers, termed Nanodiscs, have been developed for studying protein-membrane interactions, allowing strict control over the local composition of the membrane surface. Nanodiscs consist of a phospholipid bilayer ringed and stabilized by two copies of “Membrane Scaffold Protein” (MSP). Engineered from apolipoprotein A-I, MSP is an amphipathic α-helical protein wrapped around a discoidal bilayer domain in a “belt” fashion [6,7]. MSPs have been optimized for high expression in E. coli and they allow spontaneous self-assembly of nanometer-scale discoidal bilayers [7]. Nanodisc self-assembly is efficient, reproducible and simple to perform, yielding monodisperse preparations whose bilayer domain sizes are under strict experimental control. The physical properties of the supported bilayers in Nano-discs have been extensively characterized, and they faithfully reflect the bilayer state in liposomes, including bilayer thickness, mean area per phospholipid, phase transition temperature (albeit slightly broadened), metal ion interactions, and ability to support a wide range of protein-membrane interactions [6,814]. Recently, next-generation Nanodiscs have been developed that encompass larger diameter bilayers. This was accomplished by lengthening the amphipathic helical “belt” of MSP with 1, 2 or 3 additional 22-mer helices, yielding Nanodiscs ranging in diameter from about 8 nm to over 12 nm [7].

Blood clotting reactions studied on nanoscale bilayers

When integral membrane proteins are included in Nanodisc self-assembly reactions, they embed into the bilayer just as they do during liposome formation [812,1517], faithfully replicating their in vivo topology. We recently demonstrated that tissue factor (TF)-containing Nanodiscs prepared with suitable mixtures of PS and PC allow the assembly of highly active TF:FVIIa complexes on nanoscale bilayers, with catalytic activities rivaling those in liposomes [17,18]. This approach precludes long-distance (up to μm scale) recruitment of PS molecules into membrane subdomains. Unlike with liposomes, the input PS content is precisely what blood clotting proteins “see” when they encounter the nanoscale bilayer surface. We found that the dissociation constant for FX binding to nanoscale bilayers decreased monotonically as the % PS increased, reaching maximal binding affinity at >80% PS. Interestingly, the number of FX binding sites also increased with increasing PS content. At saturation, 8.4 FX molecules bound per leaflet (or about 8 PS molecules per bound FX), consistent with the idea that a FX binding site consists of a small cluster of PS molecules. Previous studies using liposomes estimated that each FX interacts with about five PS molecules [19].

Activation of FX by TF:FVIIa on nanobilayers exhibited maximal catalytic efficiencies at 70% PS or higher, and were comparable to rates observed with TF-liposomes containing 20–30% PS [17]. These results argue that extremely high local PS content is required for optimal assembly and function of the TF:FVIIa complex, as might be found on membrane “hot spots” containing locally high PS concentrations.

This study also allowed us to address a long-standing question regarding substrate delivery to membrane-bound proteases such as TF:FVIIa. One can imagine at least two different mechanisms of substrate presentation to TF:FVIIa: Solution-phase FX might bind directly to the membrane-bound TF:FVIIa complex; or membrane-bound FX molecules might randomly move on the membrane surface via lateral diffusion or hopping to encounter TF:FVIIa [1,2022]. Unlike the situation on liposomes, TF:FVIIa on Nanodiscs cannot access a large pool of membrane-bound FX. Instead, the nanobilayers can bind at most five or six FX molecules, which will be converted to FXa within two or three seconds. However, we observed sustained, linear rates of FX activation over 20 minute time courses, during which at least 2400 FX molecules were activated per TF:FVIIa [17]. The fact that turnover rates obtained with TF-Nanodiscs rival those of TF-liposomes demonstrates that the TF:FVIIa complex is not dependent on a large, preexisting pool of membrane-bound FX to serve as substrate.

We are now extending our studies using nanoscale bilayers to investigating the phospholipid dependence of the assembly and activity of other protease-cofactor pairs in blood clotting. We recently found that highly active prothrombinase complexes (FVa:FXa complexes) can be assembled on Nanodiscs engineered to encompass 12 nm-diameter phospholipid bilayers. The larger size of FVa (about four times the size of TF) necessitated the use of larger nanobilayer surfaces. Interestingly, the detailed phospholipid requirements of the prothrombinase differ from those of the TF:FVIIa complex (unpublished observations).

Computational approaches to studying clotting factor-membrane interactions on nanoscale bilayers

Although a number of x-ray crystal structures of clotting proteins have been solved, none of the structures include a membrane surface. For this reason, we lack a detailed, atomic-resolution understanding of how blood clotting proteins interact with phospholipid bilayers. On the other hand, recent advances in both computing power and in molecular dynamics (MD) methods now make it possible to conduct large-scale, all-atom MD simulations over meaningful time scales of membrane proteins interacting with phospholipid bilayers. The first large-scale MD simulation of a GLA domain interacting with a PS bilayer showed that the FVIIa GLA domain interacts simultaneously with multiple PS molecules [23]. This MD simulation also revealed quite different interaction modes between the GLA domain and various PS molecules, involving interactions between PS and the tightly-bound calcium ions of the GLA domain, as well as direct protein-lipid interactions. Of particular interest, some of the PS-GLA domain interactions involved the serine headgroup of PS, others were predominantly with the phosphate moiety, and some involved both the serine and the phosphate of PS. In contrast to previous ideas about the interaction of GLA domains with membrane surfaces (which propose rather shallow penetration of the GLA domain into the bilayer), this model suggests that the structurally bound Ca2+ ions of the GLA domain are deeply immersed in the PS headgroup layer, at about the level of the phosphates. The so-called ω-loop of the GLA domain (containing three exposed hydrophobic side chains) is also fully inserted into the hydrophobic core of the bilayer [23]. Interestingly, some of the structurally bound Ca2+ ions of the GLA domain do not directly participate in membrane binding, but instead stabilize GLA domain folding, while other Ca2+ ions directly participate in anchoring the GLA domain to the membrane. In addition, membrane binding of the GLA domain is also stabilized by direct interactions between PS and certain amino acid side chains that are positioned optimally to reach the membrane head groups [23]. Additional MD simulations are underway that are revealing the membrane binding modes of other blood clotting proteins.

Solid-state NMR studies of protein-membrane interactions employing nanoscale bilayers

Solution-based NMR studies of proteins interacting with detergent micelles or bicelles [24] are feasible with modern high-field methods, and high-resolution structures of membrane proteins have been solved, including prominent recent examples [2527]. However, the detailed lipid structure is not accurately reproduced in these sample preparations, and solution NMR investigations are ultimately limited by the rate of molecular tumbling of large lipid-protein complexes. On the other hand, magic-angle spinning solid-state NMR methods enable high-resolution studies in liposomes or Nanodiscs [28,29]. We have recently developed techniques for atomic-resolution structure determinations by solid-state NMR [30], and have demonstrated that most of the steps for structure determination can be applied directly to membrane-embedded systems; for example, we recently assigned chemical shifts of the helical membrane protein, DsbB [31]. The combination of new solid-state NMR methods and the ability to assemble clotting proteins on Nanodiscs offers tremendous possibilities for studying complexes of large, membrane-associated proteins in their native lipid environments. We are currently applying these technologies to solving the structures of key protein-membrane complexes in the blood clotting system and anticipate that these studies will reveal fundamentally new types of structural information at atomistic detail. For example, the precise conformations of PS and PC headgroups will derive from internuclear distance measurements among 13C, 15N, 31P and 1H nuclei. Site-resolved correlations between lipid and protein molecules will enable an experimental confirmation and elaboration of the MD-based GLA domain insertion models discussed above. And finally, the conformational changes within GLA domains and interfacial residues in the TF:FVIIa complex will be probed directly to shed light on this important region of the complex, which has so far been invisible to high-resolution structural methods.

Acknowledgments

Studies in the authors’ laboratories were supported by grants HL47014 (J.H.M.), GM33775 (S.G.S.), GM75937 and GM79530 (C.M.R.) from the NIH; predoctoral fellowship 0610028Z (V.S.P.) and postdoctoral fellowship 0920045G (R.L.D.) from the American Heart Association.

Footnotes

Disclosure of conflicts of interest

Some of the authors are coinventors on pending patent applications covering technologies mentioned in this article.

References

1. Zwaal RFA, Comfurius P, Bevers EM. Lipid-protein interactions in blood coagulation. Biochim Biophys Acta. 1998;1376:433–53. [PubMed]
2. Lagerholm BC, Weinreb GE, Jacobson K, Thompson NL. Detecting microdomains in intact cell membranes. Annu Rev Phys Chem. 2005;56:309–36. [PubMed]
3. Mouritsen OG, Zuckermann MJ. What’s so special about cholesterol? Lipids. 2004;39:1101–13. [PubMed]
4. Haverstick DM, Glaser M. Visualization of Ca2+-induced phospholipid domains. Proc Natl Acad Sci U S A. 1987;84:4475–9. [PubMed]
5. Yang L, Glaser M. Formation of membrane domains during the activation of protein kinase C. Biochemistry. 1996;35:13966–74. [PubMed]
6. Shaw AW, McLean MA, Sligar SG. Phospholipid phase transitions in homogeneous nanometer scale bilayer discs. FEBS Lett. 2004;556:260–4. [PubMed]
7. Denisov IG, Grinkova YV, Lazarides AA, Sligar SG. Directed self-assembly of monodisperse phospholipid bilayer Nanodiscs with controlled size. J Am Chem Soc. 2004;126:3477–87. [PubMed]
8. Bayburt TH, Carlson JW, Sligar SG. Reconstitution and imaging of a membrane protein in a nanometer-size phospholipid bilayer. J Struct Biol. 1998;123:37–44. [PubMed]
9. Bayburt TH, Sligar SG. Single-molecule height measurements on microsomal cytochrome P450 in nanometer-scale phospholipid bilayer disks. Proc Natl Acad Sci U S A. 2002;99:6725–30. [PubMed]
10. Bayburt TH, Sligar SG. Self-assembly of single integral membrane proteins into soluble nanoscale phospholipid bilayers. Protein Sci. 2003;12:2476–81. [PubMed]
11. Sligar SG. Finding a single-molecule solution for membrane proteins. Biochem Biophys Res Commun. 2003;312:115–9. [PubMed]
12. Baas BJ, Denisov IG, Sligar SG. Homotropic cooperativity of monomeric cytochrome P450 3A4 in a nanoscale native bilayer environment. Arch Biochem Biophys. 2004;430:218–28. [PubMed]
13. Shih AY, Denisov IG, Phillips JC, Sligar SG, Schulten K. Molecular dynamics simulations of discoidal bilayers assembled from truncated human lipoproteins. Biophys J. 2005;88:548–56. [PubMed]
14. Denisov IG, McLean MA, Shaw AW, Grinkova YV, Sligar SG. Thermotropic phase transition in soluble nanoscale lipid bilayers. J Phys Chem B. 2005;109:15580–8. [PMC free article] [PubMed]
15. Civjan NR, Bayburt TH, Schuler MA, Sligar SG. Direct solubilization of heterologously expressed membrane proteins by incorporation into nanoscale lipid bilayers. BioTechniques. 2003;35:556–3. [PubMed]
16. Leitz AJ, Bayburt TH, Barnakov AN, Springer BA, Sligar SG. Functional reconstitution of Beta2-adrenergic receptors utilizing self-assembling Nanodisc technology. BioTechniques. 2006;40:601–2. 604, 606. [PubMed]
17. Shaw AW, Pureza VS, Sligar SG, Morrissey JH. The local phospholipid environment modulates the activation of blood clotting. J Biol Chem. 2007;282:6556–63. [PubMed]
18. Morrissey JH, Pureza V, vis-Harrison RL, Sligar SG, Ohkubo YZ, Tajkhorshid E. Blood clotting reactions on nanoscale phospholipid bilayers. Thromb Res. 2008;122 (Suppl 1):S23–S26. [PMC free article] [PubMed]
19. Nelsestuen GL, Broderius M. Interaction of prothrombin and blood-clotting factor X with membranes of varying composition. Biochemistry. 1977;16:4172–7. [PubMed]
20. Krishnaswamy S, Field KA, Edgington TS, Morrissey JH, Mann KG. Role of the membrane surface in the activation of human coagulation factor X. J Biol Chem. 1992;267:26110–20. [PubMed]
21. Forman SD, Nemerson Y. Membrane-dependent coagulation reaction is independent of the concentration of phospholipid-bound substrate: Fluid-phase factor X regulates the extrinsic system. Proc Natl Acad Sci USA. 1986;83:4675–9. [PubMed]
22. Bom VJ, Bertina RM. The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation Factor X by activated Factor VII. Biochem J. 1990;265:327–36. [PubMed]
23. Ohkubo YZ, Tajkhorshid E. Distinct structural and adhesive roles of Ca2+ in membrane binding of blood coagulation factors. Structure. 2008;16:72–81. [PubMed]
24. Krueger-Koplin RD, Sorgen PL, Krueger-Koplin ST, Rivera-Torres IO, Cahill SM, Hicks DB, Grinius L, Krulwich TA, Girvin ME. An evaluation of detergents for NMR structural studies of membrane proteins. J Biomol NMR. 2004;28:43–57. [PubMed]
25. Zhou Y, Cierpicki T, Jimenez RH, Lukasik SM, Ellena JF, Cafiso DS, Kadokura H, Beckwith J, Bushweller JH. NMR solution structure of the integral membrane enzyme DsbB: functional insights into DsbB-catalyzed disulfide bond formation. Mol Cell. 2008;31:896–908. [PMC free article] [PubMed]
26. Liang B, Tamm LK. Structure of outer membrane protein G by solution NMR spectroscopy. Proc Natl Acad Sci U S A. 2007;104:16140–5. [PubMed]
27. Hiller S, Garces RG, Malia TJ, Orekhov VY, Colombini M, Wagner G. Solution structure of the integral human membrane protein VDAC-1 in detergent micelles. Science. 2008;321:1206–10. [PMC free article] [PubMed]
28. Li Y, Kijac AZ, Sligar SG, Rienstra CM. Structural analysis of nanoscale self-assembled discoidal lipid bilayers by solid-state NMR spectroscopy. Biophys J. 2006;91:3819–28. [PubMed]
29. Kijac AZ, Li Y, Sligar SG, Rienstra CM. Magic-angle spinning solid-state NMR spectroscopy of nanodisc-embedded human CYP3A4. Biochemistry. 2007;46:13696–703. [PMC free article] [PubMed]
30. Franks WT, Wylie BJ, Schmidt HL, Nieuwkoop AJ, Mayrhofer RM, Shah GJ, Graesser DT, Rienstra CM. Dipole tensor-based atomic-resolution structure determination of a nanocrystalline protein by solid-state NMR. Proc Natl Acad Sci U S A. 2008;105:4621–6. [PubMed]
31. Li Y, Berthold DA, Gennis RB, Rienstra CM. Chemical shift assignment of the transmembrane helices of DsbB, a 20-kDa integral membrane enzyme, by 3D magic-angle spinning NMR spectroscopy. Protein Sci. 2008;17:199–204. [PubMed]